/ADDV-B.ST

ADDV-B.ST Stock - ADDvise Group AB (publ)

Q: What is the analyst price target for ADDV-B.ST?

Analyst price target information is not currently available for ADDV-B.ST.

Q: What is ADDV-B.ST's market cap?

Market capitalization information is not currently available for ADDV-B.ST.

Healthcare|Medical - Devices|STO

$1.62-0.25%

$0.00 (-0.25%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $1.78

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ADDV-B.ST

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.41

52W High$3.75

52W Low$0.99

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.67B	$1.37B	$951.52M	$465.95M	$358.49M
Gross Profit	$906.70M	$893.50M	$575.02M	$216.56M	$138.10M
Gross Margin	54.3%	65.1%	60.4%	46.5%	38.5%
Operating Income	$292.90M	$316.80M	$157.20M	$43.55M	$34.26M
Net Income	$90.00M	$103.50M	$81.10M	$2.81M	$14.64M
Net Margin	5.4%	7.5%	8.5%	0.6%	4.1%
EPS	$0.46	$0.56	$0.46	$0.02	$0.15

Company Overview

ADDvise Group AB (publ) supplies equipment to healthcare and research facilities in private and public sectors in Sweden, rest of Europe, North America, Africa, and Asia. The company's Lab business unit designs, manufactures, and sells clean room systems and safety ventilation to laboratories, and scales to the research, industrial and grocery sectors. It is also involved in sale of equipment to laboratories, including centrifuges, water baths, and environmental chambers, and service and maintenance of scales, laboratory equipment, and storage of products. Its Healthcare business unit engages in the design, manufacture, and sale of the surgical tables, healthcare, and safety products, medtech cables, connection systems, orthopedic implants, stents for foot and ankle surgery, equipment, and software for monitoring patients, as well as operates online pharmacy. This segment also offers sale of consumable materials for healthcare, ultrasound systems, radiographic equipment, and examination tables for urology and gynecology. In addition, the company supplies laboratory furnishings and apparatus. ADDvise Group AB (publ) was founded in 1989 and is headquartered in Stockholm, Sweden.

Visit Website

Earnings History & Surprises

ADDV-B.ST

Beat Rate

67%

Last 15 quarters

Avg Surprise

+50.6%

EPS vs Estimate

Beats / Misses

10/5

Last 12 quarters

Latest EPS

$0.09

Q4 2025

EPS Surprise History

Q3 23

+142.8%

$0.18vs$0.08

Q1 24

+63.0%

$0.16vs$0.10

Q2 24

+151.9%

$0.22vs$0.09

Q3 24

+158.3%

$0.15vs$0.06

Q4 24

+36.8%

$0.06vs$0.04

Q1 25

-41.2%

$0.03vs$0.05

Q2 25

+43.1%

$0.13vs$0.09

Q4 25

+144.1%

$0.09vs$0.04

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 7, 2026	—	—	—	—
Q1 2026	Feb 19, 2026	—	—	—	—
Q4 2025	Oct 23, 2025	$0.04	$0.09	+144.1%	✓ BEAT
Q2 2025	May 9, 2025	$0.09	$0.13	+43.1%	✓ BEAT
Q1 2025	Feb 20, 2025	$0.05	$0.03	-41.2%	✗ MISS
Q4 2024	Oct 24, 2024	$0.04	$0.06	+36.8%	✓ BEAT
Q3 2024	Jul 18, 2024	$0.06	$0.15	+158.3%	✓ BEAT
Q2 2024	Apr 18, 2024	$0.09	$0.22	+151.9%	✓ BEAT
Q1 2024	Feb 22, 2024	$0.10	$0.16	+63.0%	✓ BEAT
Q3 2023	Sep 30, 2023	$0.08	$0.18	+142.8%	✓ BEAT
Q2 2023	Jun 30, 2023	$0.06	$0.02	-69.0%	✗ MISS
Q1 2023	Mar 31, 2023	$0.08	$0.20	+140.4%	✓ BEAT
Q4 2022	Dec 31, 2022	$0.16	$0.16	-1.1%	✗ MISS
Q3 2022	Sep 30, 2022	$0.08	$0.19	+136.2%	✓ BEAT
Q2 2022	Jun 30, 2022	$0.06	$0.11	+68.3%	✓ BEAT
Q1 2022	Mar 31, 2022	$0.04	$0.00	-99.0%	✗ MISS
Q4 2021	Dec 31, 2021	—	$0.01	—	—
Q3 2021	Sep 30, 2021	$0.07	$-0.01	-115.3%	✗ MISS
Q2 2021	Jun 30, 2021	—	$0.00	—	—
Q1 2021	Mar 31, 2021	—	$0.02	—	—

Frequently Asked Questions about ADDV-B.ST

What is ADDV-B.ST's current stock price?

ADDvise Group AB (publ) (ADDV-B.ST) is currently trading at $1.62 per share. The stock has moved -0.25% today.

What is the analyst price target for ADDV-B.ST?

No analyst price targets are currently available for this stock.

What sector is ADDvise Group AB (publ) in?

ADDvise Group AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.

What is ADDV-B.ST's market cap?

ADDvise Group AB (publ) has a market capitalization of $0.99 billion, making it a small-cap company.

Does ADDV-B.ST pay dividends?

No, ADDvise Group AB (publ) does not currently pay a dividend to shareholders.